HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SIHUAN PHARM

0.875

-0.030-3.31%

Volume:30.37M

Turnover:26.59M

Market Cap:7.99B

PE:38.07

High:0.900

Open:0.900

Low:0.865

Close:0.905

52wk High:1.896

52wk Low:0.810

Shares:9.13B

HK Float Shares:9.13B

Volume Ratio:1.18

T/O Rate:0.33%

Dividend:0.02

Dividend Rate:2.60%

EPS(LYR):0.023

ROE:3.13%

ROA:2.69%

PB:1.17

PE(LYR):38.07

PS:2.61

Loading ...

Overview Company News Filings

Asian Penny Stocks Under US$10B Market Cap: 3 Picks To Consider

Simply Wall St.

Assessing Sihuan Pharmaceutical Holdings Group’s Valuation After Earnings Turnaround And Positive Bireociclib Phase 3 Results

Simply Wall St.

BRIEF-Sihuan Pharma Signs Strategic Collaboration With Biocytogen For AI-Driven Drug R&D

SIHUAN PHARM and BIOCYTOGEN-B Forge Strategic Alliance to Accelerate Innovative Drug Development in Weight Loss and Other Areas Using AI-Powered Human Antibody Platform

Sihuan Pharm partners with Biocytogen to accelerate AI-driven fully human antibody R&D for next-gen weight-loss therapy

Bulletin Express

Sihuan Pharma signs strategic R&D collaboration with Biocytogen on AI antibody platform

Sihuan Pharma - First Project Focuses on Next-Generation Weight Loss Drug

THOMSON REUTERS

Sihuan Pharma: March 2026 Share Capital Stable, No New Issuances or Treasury Movements

Bulletin Express

Sihuan Pharmaceutical Declares RMB 0.0096 Final Dividend for FY 2025

Bulletin Express

Sihuan Pharmaceutical Returns to Profitability with FY Net Income of 180 Million Yuan

Sihuan Pharmaceutical 2025 Results: Revenue Climbs 37.7%, Turns Profitable on Medical Aesthetics Surge

Bulletin Express

Sihuan Pharma FY25 revenue climbs 37.7% to RMB 2.6 billion

Sihuan Pharma - FY Profit Attributable RMB179.7 Mln

THOMSON REUTERS

Sihuan Pharma - Final Cash Dividend of RMB0.96 Cents per Share

THOMSON REUTERS

Xuanzhu Biopharma FY25 loss narrows 55.9% to RMB 250 million

Sihuan Pharmaceutical unit publishes BRIGHT-2 Phase 3 results for biloxcilib plus fulvestrant in JAMA Oncology

Xuanzhu Biopharmaceutical reports BRIGHT-2 Phase 3 results for Bireociclib plus fulvestrant in HR+/HER2- breast cancer

Xuanzhu Biopharmaceutical completes enrollment of 500 patients in China Phase 3 trial of anaprazole sodium enteric-coated tablets for reflux esophagitis

Xuanzhu Biopharmaceutical completes enrollment of 500 subjects in China Phase III reflux esophagitis trial of anaprazole sodium tablets

Sihuan Pharma (00460) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/00460/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"00460","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"00460\",,,,,undefined,":{"symbol":"00460","market":"HK","secType":"STK","nameCN":"SIHUAN PHARM","latestPrice":0.875,"timestamp":1787299688003,"preClose":0.905,"halted":0,"volume":30368282,"delay":0,"changeRate":-0.03314917127071826,"floatShares":9126000000,"shares":9126000000,"eps":0.02298204619582262,"marketStatus":"Not Yet Opened","change":-0.03,"latestTime":"08-21 16:08:08","open":0.9,"high":0.9,"low":0.865,"amount":26594219,"amplitude":0.038674,"askPrice":0.88,"askSize":1438000,"bidPrice":0.875,"bidSize":877000,"shortable":3,"etf":0,"ttmEps":0.022980879594492885,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"listingDate":1288195200000,"exchange":"SEHK","adjPreClose":0.905,"dividendRate":0.025683,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":1.1770368171789696,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"00460\",,,,,undefined,":{"symbol":"00460","floatShares":9126000000,"roa":"2.69%","roe":"3.13%","lyrEps":0.022982,"volumeRatio":1.1770368171789696,"shares":9126000000,"dividePrice":0.022749,"high":0.9,"amplitude":0.038674,"preClose":0.905,"low":0.865,"week52Low":0.81,"pbRate":"1.17","psRate":"2.61","week52High":1.896,"institutionHeld":0,"latestPrice":0.875,"committee":-0.242333,"eps":0.02298202046336587,"divideRate":0.025999,"volume":30368282,"delay":0,"ttmEps":0.02298085386334235,"open":0.9,"prevYearClose":1.215,"prevWeekClose":0.875,"prevMonthClose":0.9,"prevQuarterClose":0.83,"fiveDayClose":0.86,"twentyDayClose":0.88,"sixtyDayClose":0.998,"earningDate":1787673600000,"dividendGrowthYears":0,"dividendGrowthRate":-0.48095238095238096,"fiveYearAvgDividendRate":0.06241727605023266},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/00460\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"00460","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null},{"date":"2026-06-30","symbol":"00460","amount":0.0109,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-07-02","defaultRemindTime":1782783000000,"name":"四环医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-16","payableDate":"2026-07-02","currency":"HKD","dateTimestamp":1782748800000,"payDate":"2026-07-16"},{"market":"HK","date":"2026-03-31","symbol":"00460","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774886400000,"reportTimeType":"pre","actualEps":null},{"date":"2025-09-26","symbol":"00460","amount":0.0109,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-09-29","defaultRemindTime":1758850200000,"name":"四环医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-10","payableDate":"2025-09-29","currency":"HKD","dateTimestamp":1758816000000,"payDate":"2025-10-10"},{"date":"2025-08-29","symbol":"00460","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"00460\",market:\"HK\",,,undefined,":[{"executeDate":"2016-09-05","recordDate":"2016-09-06","paymentDate":"2016-09-15","value":0.016,"currency":"HKD"},{"executeDate":"2017-06-22","recordDate":"2017-06-23","paymentDate":"2017-07-05","value":0.061,"currency":"HKD"},{"executeDate":"2017-09-01","recordDate":"2017-09-04","paymentDate":"2017-09-13","value":0.021,"currency":"HKD"},{"executeDate":"2018-06-07","recordDate":"2018-06-08","paymentDate":"2018-06-20","value":0.016,"currency":"HKD"},{"executeDate":"2018-10-18","recordDate":"2018-10-19","paymentDate":"2018-10-31","value":0.005,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"00460\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1776182400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/00460\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"00460","date":"2026-08-21","current":38.065792,"percent":0.934906,"low":-209.490836,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"high":64.244472,"avg":-43.641374,"sd":66.638134,"marketCap":7894075180},"quantilePoints":[{"date":"2021-08-27","current":35.494026,"twenty":-27.877152,"median":40.988008,"eighty":51.61407,"marketCap":20220393920},{"date":"2021-09-03","current":18.974009,"twenty":-25.966242,"median":39.047216,"eighty":51.471473,"marketCap":21354247785},{"date":"2021-09-10","current":18.339152,"twenty":-25.715994,"median":38.415307,"eighty":51.182712,"marketCap":20692833031},{"date":"2021-09-17","current":17.797528,"twenty":-25.433432,"median":37.439142,"eighty":51.151715,"marketCap":20022302276},{"date":"2021-09-24","current":16.774147,"twenty":-24.842427,"median":37.187111,"eighty":50.92554,"marketCap":18879724412},{"date":"2021-09-30","current":13.865815,"twenty":-23.806841,"median":36.949192,"eighty":50.630372,"marketCap":15658551261},{"date":"2021-10-08","current":13.108229,"twenty":-22.959741,"median":35.979756,"eighty":50.46473,"marketCap":14802340263},{"date":"2021-10-15","current":13.579123,"twenty":-21.594681,"median":35.600566,"eighty":50.364548,"marketCap":15344610065},{"date":"2021-10-22","current":14.332089,"twenty":-19.026938,"median":35.395632,"eighty":50.002562,"marketCap":16311750418},{"date":"2021-10-29","current":13.511153,"twenty":-15.708182,"median":35.247968,"eighty":49.588904,"marketCap":15339395937},{"date":"2021-11-05","current":12.246285,"twenty":-12.19519,"median":34.988251,"eighty":49.223932,"marketCap":13926283816},{"date":"2021-11-12","current":12.011055,"twenty":-11.77144,"median":27.258382,"eighty":48.839902,"marketCap":13715098832},{"date":"2021-11-19","current":12.928135,"twenty":-11.732461,"median":19.402854,"eighty":48.776182,"marketCap":14741398745},{"date":"2021-11-26","current":13.414784,"twenty":-11.673993,"median":19.144523,"eighty":48.710704,"marketCap":15301198697},{"date":"2021-12-03","current":12.246976,"twenty":-11.652916,"median":18.619604,"eighty":48.61427,"marketCap":13994998809},{"date":"2021-12-10","current":12.796652,"twenty":-11.595138,"median":18.005665,"eighty":48.548604,"marketCap":14648098753},{"date":"2021-12-17","current":11.500484,"twenty":-11.464523,"median":17.782952,"eighty":48.516654,"marketCap":13155298880},{"date":"2021-12-24","current":11.652483,"twenty":-11.370198,"median":17.227082,"eighty":48.404807,"marketCap":13341898864},{"date":"2021-12-31","current":12.033737,"twenty":-11.352806,"median":16.727584,"eighty":48.276843,"marketCap":13808398824},{"date":"2022-01-07","current":11.997981,"twenty":11.916847,"median":12.033737,"eighty":12.311613,"marketCap":13715098832},{"date":"2022-01-14","current":13.437855,"twenty":11.991179,"median":12.354107,"eighty":13.277084,"marketCap":15394498689},{"date":"2022-01-21","current":12.838373,"twenty":12.019435,"median":12.923546,"eighty":13.260333,"marketCap":14741398745},{"date":"2022-01-28","current":11.730737,"twenty":11.950402,"median":12.53206,"eighty":13.186191,"marketCap":13435198856},{"date":"2022-02-04","current":12.062504,"twenty":11.904542,"median":12.319594,"eighty":13.174667,"marketCap":13808398824},{"date":"2022-02-11","current":13.095597,"twenty":11.980976,"median":12.566572,"eighty":13.174667,"marketCap":15021298721},{"date":"2022-02-18","current":14.893251,"twenty":11.997981,"median":12.857781,"eighty":13.345619,"marketCap":17167198539},{"date":"2022-02-25","current":13.968456,"twenty":12.033737,"median":12.929214,"eighty":13.75323,"marketCap":16140898626},{"date":"2022-03-04","current":12.913857,"twenty":12.062504,"median":12.988177,"eighty":13.600429,"marketCap":14927998729},{"date":"2022-03-11","current":13.175885,"twenty":12.074235,"median":12.990943,"eighty":13.53943,"marketCap":15207898705},{"date":"2022-03-18","current":13.228631,"twenty":12.062504,"median":12.970168,"eighty":13.471303,"marketCap":15207898705},{"date":"2022-03-25","current":13.390384,"twenty":12.074235,"median":13.001622,"eighty":13.556612,"marketCap":15394498689},{"date":"2022-04-01","current":28.56237,"twenty":12.077655,"median":13.05005,"eighty":13.891083,"marketCap":14648098753},{"date":"2022-04-08","current":27.095221,"twenty":12.083977,"median":13.125304,"eighty":14.447354,"marketCap":13901698816},{"date":"2022-04-14","current":25.865073,"twenty":12.119208,"median":13.175276,"eighty":14.953028,"marketCap":13248598872},{"date":"2022-04-22","current":24.501555,"twenty":12.191086,"median":13.216054,"eighty":20.896029,"marketCap":12315598951},{"date":"2022-04-29","current":23.770426,"twenty":12.311154,"median":13.345619,"eighty":23.810765,"marketCap":11755798999},{"date":"2022-05-06","current":19.97461,"twenty":12.403513,"median":13.387495,"eighty":23.824211,"marketCap":9796499166},{"date":"2022-05-13","current":22.275517,"twenty":12.497547,"median":13.437855,"eighty":23.770426,"marketCap":10729499086},{"date":"2022-05-20","current":23.495458,"twenty":12.566572,"median":13.505367,"eighty":23.495458,"marketCap":11475899023},{"date":"2022-05-27","current":20.456885,"twenty":12.635159,"median":13.600429,"eighty":23.495458,"marketCap":9983099150},{"date":"2022-06-02","current":22.059164,"twenty":12.719893,"median":13.891083,"eighty":23.428031,"marketCap":10822799078},{"date":"2022-06-10","current":22.782826,"twenty":12.818914,"median":14.187223,"eighty":23.405861,"marketCap":11102699055},{"date":"2022-06-17","current":22.61617,"twenty":12.869426,"median":14.893251,"eighty":23.399001,"marketCap":11009399063},{"date":"2022-06-24","current":24.053703,"twenty":12.896899,"median":15.198068,"eighty":23.405861,"marketCap":11755798999},{"date":"2022-06-30","current":24.477649,"twenty":12.909045,"median":17.731175,"eighty":23.688539,"marketCap":11942398983},{"date":"2022-07-08","current":24.643513,"twenty":12.91967,"median":20.576157,"eighty":24.071679,"marketCap":12035698975},{"date":"2022-07-15","current":21.788884,"twenty":12.926947,"median":21.331232,"eighty":24.071679,"marketCap":10542899102},{"date":"2022-07-22","current":22.738077,"twenty":12.951049,"median":21.927975,"eighty":23.924075,"marketCap":11009399063},{"date":"2022-07-29","current":21.55561,"twenty":12.971081,"median":21.986908,"eighty":23.797318,"marketCap":10449599110},{"date":"2022-08-05","current":21.417702,"twenty":12.984459,"median":21.788884,"eighty":23.729375,"marketCap":10356299118},{"date":"2022-08-12","current":21.388554,"twenty":12.99735,"median":21.539113,"eighty":23.688539,"marketCap":10356299118},{"date":"2022-08-19","current":19.074515,"twenty":13.008905,"median":21.417702,"eighty":23.569099,"marketCap":9143399221},{"date":"2022-08-26","current":20.011662,"twenty":13.057307,"median":21.382076,"eighty":23.444888,"marketCap":9516599190},{"date":"2022-09-02","current":-50.414444,"twenty":12.984459,"median":21.247144,"eighty":23.407189,"marketCap":8863499245},{"date":"2022-09-09","current":-50.607103,"twenty":12.91967,"median":20.858756,"eighty":23.400384,"marketCap":8863499245},{"date":"2022-09-16","current":-47.853042,"twenty":12.853899,"median":20.604805,"eighty":23.393338,"marketCap":8303699293},{"date":"2022-09-23","current":-43.307663,"twenty":12.525157,"median":20.456885,"eighty":23.36815,"marketCap":7370699372},{"date":"2022-09-30","current":-41.583628,"twenty":12.107991,"median":19.993136,"eighty":23.33352,"marketCap":7090799396},{"date":"2022-10-07","current":-42.133205,"twenty":12.06485,"median":19.637124,"eighty":23.316565,"marketCap":7184099388},{"date":"2022-10-14","current":-40.925738,"twenty":11.919829,"median":19.38703,"eighty":23.276922,"marketCap":6904199412},{"date":"2022-10-21","current":-41.207935,"twenty":11.75473,"median":18.999282,"eighty":23.214673,"marketCap":6904199412},{"date":"2022-10-28","current":-37.373897,"twenty":-27.390428,"median":15.48774,"eighty":23.127451,"marketCap":6251099468},{"date":"2022-11-04","current":-43.090604,"twenty":-38.423466,"median":14.959982,"eighty":23.068326,"marketCap":7277399380},{"date":"2022-11-11","current":-44.352681,"twenty":-39.706495,"median":14.612812,"eighty":22.970466,"marketCap":7557299356},{"date":"2022-11-18","current":-49.450162,"twenty":-40.88532,"median":13.933713,"eighty":22.927159,"marketCap":8396999285},{"date":"2022-11-25","current":-45.968734,"twenty":-42.005475,"median":13.75323,"eighty":22.88204,"marketCap":7743899340},{"date":"2022-12-02","current":-46.277717,"twenty":-42.783845,"median":13.548021,"eighty":22.8258,"marketCap":7930499325},{"date":"2022-12-09","current":-49.088418,"twenty":-43.299013,"median":13.457621,"eighty":22.784854,"marketCap":8490299277},{"date":"2022-12-16","current":-50.825271,"twenty":-44.19667,"median":13.388939,"eighty":22.776063,"marketCap":8770199253},{"date":"2022-12-23","current":-48.647344,"twenty":-44.632402,"median":13.345619,"eighty":22.746825,"marketCap":8396999285},{"date":"2022-12-30","current":-50.733601,"twenty":-44.88627,"median":13.246799,"eighty":22.740264,"marketCap":8863499245},{"date":"2023-01-06","current":-53.389335,"twenty":-45.265509,"median":13.18968,"eighty":22.735439,"marketCap":9423299198},{"date":"2023-01-13","current":-53.424808,"twenty":-45.938929,"median":13.15501,"eighty":22.731574,"marketCap":9609899182},{"date":"2023-01-20","current":-52.840862,"twenty":-46.59674,"median":13.05005,"eighty":22.727682,"marketCap":9423299198},{"date":"2023-01-27","current":-54.922334,"twenty":-47.03062,"median":13.007691,"eighty":22.726024,"marketCap":9796499166},{"date":"2023-02-03","current":-57.761641,"twenty":-47.472906,"median":12.974732,"eighty":22.707873,"marketCap":10356299118},{"date":"2023-02-10","current":-52.875612,"twenty":-47.832379,"median":12.92638,"eighty":22.61617,"marketCap":9423299198},{"date":"2023-02-17","current":-50.737918,"twenty":-48.647344,"median":12.901826,"eighty":22.608311,"marketCap":8956799237},{"date":"2023-02-24","current":-49.760718,"twenty":-49.165946,"median":12.789725,"eighty":22.583157,"marketCap":8676899261},{"date":"2023-03-03","current":-51.036808,"twenty":-49.265743,"median":12.566572,"eighty":22.527072,"marketCap":8956799237},{"date":"2023-03-10","current":-43.382514,"twenty":-48.330408,"median":-46.012402,"eighty":-43.703866,"marketCap":7557299356},{"date":"2023-03-17","current":-43.497246,"twenty":-11.799375,"median":9.135444,"eighty":13.964446,"marketCap":7650599348},{"date":"2023-03-24","current":-43.003515,"twenty":-11.923183,"median":9.108489,"eighty":13.964446,"marketCap":7650599348},{"date":"2023-03-31","current":-3.369265,"twenty":-11.914105,"median":9.06444,"eighty":13.922755,"marketCap":7370699372},{"date":"2023-04-06","current":-3.499469,"twenty":-11.905028,"median":9.059545,"eighty":13.910863,"marketCap":7650599348},{"date":"2023-04-14","current":-3.62392,"twenty":-11.923183,"median":8.997567,"eighty":13.934648,"marketCap":7930499325},{"date":"2023-04-21","current":-3.412504,"twenty":-11.923183,"median":8.985211,"eighty":13.934648,"marketCap":7463999364},{"date":"2023-04-28","current":-3.438104,"twenty":-11.923183,"median":8.941609,"eighty":13.934648,"marketCap":7463999364},{"date":"2023-05-05","current":-3.475381,"twenty":-11.923183,"median":8.913332,"eighty":13.934648,"marketCap":7557299356},{"date":"2023-05-12","current":-3.369868,"twenty":-11.923183,"median":8.886738,"eighty":13.934648,"marketCap":7277399380},{"date":"2023-05-19","current":-3.374111,"twenty":-11.923183,"median":8.84028,"eighty":13.934648,"marketCap":7184099388},{"date":"2023-05-25","current":-3.344052,"twenty":-11.914105,"median":8.76622,"eighty":13.922755,"marketCap":7090799396},{"date":"2023-06-02","current":-3.399581,"twenty":-11.923183,"median":8.634294,"eighty":13.934648,"marketCap":7184099388},{"date":"2023-06-09","current":-3.271849,"twenty":-11.923183,"median":8.544591,"eighty":13.934648,"marketCap":6904199412},{"date":"2023-06-16","current":-3.287594,"twenty":-11.923183,"median":8.325238,"eighty":13.934648,"marketCap":6904199412},{"date":"2023-06-23","current":-3.260953,"twenty":-11.923183,"median":8.22569,"eighty":13.934648,"marketCap":6810899420},{"date":"2023-06-30","current":-3.516112,"twenty":-11.923183,"median":8.122554,"eighty":13.934648,"marketCap":7277399380},{"date":"2023-07-07","current":-3.387485,"twenty":-11.914105,"median":8.052356,"eighty":13.922755,"marketCap":6997499404},{"date":"2023-07-14","current":-3.296067,"twenty":-11.914105,"median":7.77723,"eighty":13.922755,"marketCap":6904199412},{"date":"2023-07-21","current":-3.311457,"twenty":-11.914105,"median":7.356217,"eighty":13.922755,"marketCap":6904199412},{"date":"2023-07-28","current":-3.449398,"twenty":-11.914105,"median":-2.287019,"eighty":13.922755,"marketCap":7184099388},{"date":"2023-08-04","current":-3.264781,"twenty":-11.914105,"median":-2.31585,"eighty":13.922755,"marketCap":6810899420},{"date":"2023-08-11","current":-3.28332,"twenty":-11.914105,"median":-2.324398,"eighty":13.922755,"marketCap":6810899420},{"date":"2023-08-18","current":-2.899285,"twenty":-11.914105,"median":-2.339675,"eighty":13.922755,"marketCap":5971199491},{"date":"2023-08-25","current":-2.988413,"twenty":-11.914105,"median":-2.355562,"eighty":13.922755,"marketCap":6157799475},{"date":"2023-09-01","current":-2.756299,"twenty":-11.914105,"median":-2.368431,"eighty":13.922755,"marketCap":5971199491},{"date":"2023-09-08","current":-2.832715,"twenty":-11.914105,"median":-2.388209,"eighty":13.922755,"marketCap":6064499483},{"date":"2023-09-15","current":-2.854165,"twenty":-11.914105,"median":-2.395927,"eighty":13.922755,"marketCap":6157799475},{"date":"2023-09-22","current":-2.779829,"twenty":-11.914105,"median":-2.415497,"eighty":13.922755,"marketCap":5971199491},{"date":"2023-09-29","current":-2.644988,"twenty":-11.905028,"median":-2.420333,"eighty":13.910863,"marketCap":5691299515},{"date":"2023-10-06","current":-2.602874,"twenty":-11.905028,"median":-2.422655,"eighty":13.910863,"marketCap":5597999523},{"date":"2023-10-13","current":-2.737106,"twenty":-11.905028,"median":-2.427741,"eighty":13.910863,"marketCap":5877899499},{"date":"2023-10-20","current":-2.654304,"twenty":-11.89595,"median":-2.443134,"eighty":13.898971,"marketCap":5691299515},{"date":"2023-10-27","current":-2.655443,"twenty":-11.905028,"median":-2.448372,"eighty":13.910863,"marketCap":5691299515},{"date":"2023-11-03","current":-2.908911,"twenty":-11.905028,"median":-2.473666,"eighty":13.910863,"marketCap":6251099468},{"date":"2023-11-10","current":-2.866093,"twenty":-11.905028,"median":-2.484636,"eighty":13.910863,"marketCap":6157799475},{"date":"2023-11-17","current":-2.883513,"twenty":-11.905028,"median":-2.491565,"eighty":13.910863,"marketCap":6251099468},{"date":"2023-11-24","current":-2.988026,"twenty":-11.905028,"median":-2.505676,"eighty":13.910863,"marketCap":6530999444},{"date":"2023-12-01","current":-2.848158,"twenty":-11.905028,"median":-2.536149,"eighty":13.910863,"marketCap":6251099468},{"date":"2023-12-08","current":-2.646304,"twenty":-11.905028,"median":-2.561957,"eighty":13.910863,"marketCap":5784599507},{"date":"2023-12-15","current":-2.673547,"twenty":-11.905028,"median":-2.583157,"eighty":13.910863,"marketCap":5877899499},{"date":"2023-12-22","current":-2.632869,"twenty":-11.905028,"median":-2.607761,"eighty":13.910863,"marketCap":5784599507},{"date":"2023-12-29","current":-2.745627,"twenty":-11.905028,"median":-2.60984,"eighty":13.910863,"marketCap":6064499483},{"date":"2024-01-05","current":-2.637506,"twenty":-11.905028,"median":-2.639856,"eighty":13.910863,"marketCap":5784599507},{"date":"2024-01-12","current":-2.678621,"twenty":-11.905028,"median":-2.644988,"eighty":13.910863,"marketCap":5877899499},{"date":"2024-01-19","current":-2.426848,"twenty":-11.905028,"median":-2.646304,"eighty":13.910863,"marketCap":5318099547},{"date":"2024-01-26","current":-2.479072,"twenty":-11.905028,"median":-2.646304,"eighty":13.910863,"marketCap":5411399539},{"date":"2024-02-02","current":-2.182657,"twenty":-11.905028,"median":-2.646304,"eighty":13.910863,"marketCap":4758299595},{"date":"2024-02-09","current":-2.342311,"twenty":-11.895406,"median":-2.644096,"eighty":13.898608,"marketCap":5131499563},{"date":"2024-02-16","current":-2.384382,"twenty":-11.89595,"median":-2.645646,"eighty":13.898971,"marketCap":5224799555},{"date":"2024-02-23","current":-2.482626,"twenty":-11.89595,"median":-2.645646,"eighty":13.898971,"marketCap":5411399539},{"date":"2024-03-01","current":-2.438302,"twenty":-11.895678,"median":-2.644988,"eighty":13.89879,"marketCap":5318099547},{"date":"2024-03-08","current":-2.351702,"twenty":-11.895678,"median":-2.644988,"eighty":13.89879,"marketCap":5131499563},{"date":"2024-03-15","current":-2.482173,"twenty":-11.895678,"median":-2.644988,"eighty":13.89879,"marketCap":5411399539},{"date":"2024-03-22","current":-2.441611,"twenty":-11.895678,"median":-2.644988,"eighty":13.89879,"marketCap":5318099547},{"date":"2024-03-28","current":-2.277553,"twenty":-11.895678,"median":-2.644988,"eighty":13.89879,"marketCap":4944899579},{"date":"2024-04-05","current":-82.564306,"twenty":-12.024696,"median":-2.653901,"eighty":13.922755,"marketCap":4826414427},{"date":"2024-04-12","current":-82.517453,"twenty":-12.053439,"median":-2.678022,"eighty":13.910863,"marketCap":4826414427},{"date":"2024-04-19","current":-80.999729,"twenty":-12.172703,"median":-2.681735,"eighty":13.910863,"marketCap":4733598765},{"date":"2024-04-26","current":-89.050676,"twenty":-12.294617,"median":-2.696365,"eighty":13.89879,"marketCap":5197677075},{"date":"2024-05-03","current":-97.068727,"twenty":-12.347799,"median":-2.720997,"eighty":13.89879,"marketCap":5661755385},{"date":"2024-05-10","current":-100.013862,"twenty":-12.43199,"median":-2.742169,"eighty":13.89879,"marketCap":5847386709},{"date":"2024-05-17","current":-96.981169,"twenty":-12.561565,"median":-2.775562,"eighty":13.89879,"marketCap":5661755385},{"date":"2024-05-24","current":-90.829186,"twenty":-12.802369,"median":-2.783534,"eighty":13.89879,"marketCap":5290492737},{"date":"2024-05-31","current":-85.961213,"twenty":-12.9722,"median":-2.82109,"eighty":13.89879,"marketCap":5012045751},{"date":"2024-06-07","current":-82.880248,"twenty":-13.0747,"median":-2.850331,"eighty":13.89879,"marketCap":4826414427},{"date":"2024-06-14","current":-89.337509,"twenty":-13.162465,"median":-2.855147,"eighty":13.89879,"marketCap":5197677075},{"date":"2024-06-21","current":-87.926264,"twenty":-13.350566,"median":-2.866093,"eighty":13.89879,"marketCap":5104861413},{"date":"2024-06-28","current":-83.075186,"twenty":-13.539773,"median":-2.899285,"eighty":13.89879,"marketCap":4821214427},{"date":"2024-07-05","current":-87.887073,"twenty":-13.831871,"median":-2.914912,"eighty":13.89879,"marketCap":5099361413},{"date":"2024-07-12","current":-89.353766,"twenty":-23.129881,"median":-2.937581,"eighty":13.89879,"marketCap":5192077075},{"date":"2024-07-19","current":-87.75652,"twenty":-27.49497,"median":-2.962287,"eighty":13.89879,"marketCap":5099361413},{"date":"2024-07-26","current":-82.662699,"twenty":-29.481842,"median":-2.988026,"eighty":13.89879,"marketCap":4821214427},{"date":"2024-08-02","current":-82.710896,"twenty":-31.051397,"median":-2.992606,"eighty":13.89879,"marketCap":4821214427},{"date":"2024-08-09","current":-83.743358,"twenty":-31.528775,"median":-3.16992,"eighty":13.89879,"marketCap":4913930089},{"date":"2024-08-16","current":-85.290276,"twenty":-32.152303,"median":-3.229351,"eighty":13.89879,"marketCap":5006645751},{"date":"2024-08-23","current":-83.358505,"twenty":-32.890641,"median":-3.231225,"eighty":13.89879,"marketCap":4913930089},{"date":"2024-08-30","current":-84.364924,"twenty":-35.838782,"median":-3.231225,"eighty":13.89879,"marketCap":5006645751},{"date":"2024-09-06","current":-122.742481,"twenty":-37.338415,"median":-3.231225,"eighty":13.89879,"marketCap":5099361413},{"date":"2024-09-13","current":-116.352005,"twenty":-39.121822,"median":-3.231225,"eighty":13.89879,"marketCap":4821214427},{"date":"2024-09-20","current":-120.106819,"twenty":-40.50159,"median":-3.230288,"eighty":13.898971,"marketCap":5006645751},{"date":"2024-09-27","current":-128.90228,"twenty":-41.473142,"median":-3.230288,"eighty":13.898971,"marketCap":5405599539},{"date":"2024-10-04","current":-160.746776,"twenty":-42.353423,"median":-3.230288,"eighty":13.898971,"marketCap":6710399428},{"date":"2024-10-10","current":-166.288706,"twenty":-42.783845,"median":-3.231225,"eighty":13.89879,"marketCap":6896799412},{"date":"2024-10-18","current":-160.383543,"twenty":-43.090604,"median":-3.230288,"eighty":13.898971,"marketCap":6617199436},{"date":"2024-10-25","current":-160.393712,"twenty":-43.385987,"median":-3.230288,"eighty":13.898971,"marketCap":6617199436},{"date":"2024-11-01","current":-162.543207,"twenty":-43.918101,"median":-3.230288,"eighty":13.898971,"marketCap":6710399428},{"date":"2024-11-08","current":-165.551727,"twenty":-44.601068,"median":-3.230288,"eighty":13.898971,"marketCap":6803599420},{"date":"2024-11-15","current":-153.57094,"twenty":-45.087779,"median":-3.230288,"eighty":13.898971,"marketCap":6244399468},{"date":"2024-11-22","current":-151.350528,"twenty":-45.919059,"median":-3.230288,"eighty":13.898971,"marketCap":6151199475},{"date":"2024-11-29","current":-158.1664,"twenty":-46.947732,"median":-3.230288,"eighty":13.898971,"marketCap":6423899452},{"date":"2024-12-06","current":-158.539828,"twenty":-47.472906,"median":-3.230288,"eighty":13.898971,"marketCap":6423899452},{"date":"2024-12-13","current":-156.551131,"twenty":-47.853042,"median":-3.230288,"eighty":13.898971,"marketCap":6330799460},{"date":"2024-12-20","current":-152.622975,"twenty":-48.647344,"median":-3.230288,"eighty":13.898971,"marketCap":6144599475},{"date":"2024-12-27","current":-150.427207,"twenty":-48.748259,"median":-3.230288,"eighty":13.898971,"marketCap":6051499483},{"date":"2025-01-03","current":-145.65607,"twenty":-49.231765,"median":-3.230288,"eighty":13.898971,"marketCap":5865299499},{"date":"2025-01-10","current":-134.606092,"twenty":-49.760718,"median":-3.230288,"eighty":13.898971,"marketCap":5399799539},{"date":"2025-01-17","current":-134.497552,"twenty":-50.352943,"median":-3.230288,"eighty":13.898971,"marketCap":5399799539},{"date":"2025-01-24","current":-131.355559,"twenty":-50.737918,"median":-3.230288,"eighty":13.898971,"marketCap":5306699547},{"date":"2025-01-28","current":-135.255702,"twenty":-50.821082,"median":-3.231225,"eighty":13.89879,"marketCap":5492899531},{"date":"2025-02-07","current":-133.7198,"twenty":-51.348886,"median":-3.229351,"eighty":13.910863,"marketCap":5399799539},{"date":"2025-02-14","current":-143.010767,"twenty":-51.820483,"median":-3.229351,"eighty":13.910863,"marketCap":5772199507},{"date":"2025-02-21","current":-140.204067,"twenty":-52.541209,"median":-3.229351,"eighty":13.910863,"marketCap":5679099515},{"date":"2025-02-28","current":-136.055611,"twenty":-52.889352,"median":-3.229351,"eighty":13.910863,"marketCap":5492899531},{"date":"2025-03-07","current":-140.105142,"twenty":-53.292951,"median":-3.228493,"eighty":13.922755,"marketCap":5679099515},{"date":"2025-03-14","current":-137.758216,"twenty":-53.706159,"median":-3.228493,"eighty":13.922755,"marketCap":5585999523},{"date":"2025-03-21","current":-146.841923,"twenty":-54.405044,"median":-3.228493,"eighty":13.922755,"marketCap":5951999491},{"date":"2025-03-28","current":-137.943443,"twenty":-56.391895,"median":-3.241626,"eighty":13.922755,"marketCap":5579999523},{"date":"2025-04-03","current":-26.523264,"twenty":-56.391895,"median":-3.251132,"eighty":13.922755,"marketCap":6137999475},{"date":"2025-04-11","current":-25.486974,"twenty":-56.391895,"median":-3.265745,"eighty":13.922755,"marketCap":5858999499},{"date":"2025-04-17","current":-25.150028,"twenty":-56.370327,"median":-3.279167,"eighty":13.910863,"marketCap":5795411709},{"date":"2025-04-25","current":-26.324914,"twenty":-56.413464,"median":-3.301031,"eighty":13.934648,"marketCap":6071383695},{"date":"2025-05-02","current":-29.45321,"twenty":-56.391895,"median":-3.309311,"eighty":13.922755,"marketCap":6807308992},{"date":"2025-05-09","current":-27.542361,"twenty":-56.413464,"median":-3.312987,"eighty":13.934648,"marketCap":6410355844},{"date":"2025-05-16","current":-26.119791,"twenty":-56.413464,"median":-3.359803,"eighty":13.934648,"marketCap":6128926308},{"date":"2025-05-23","current":-34.592965,"twenty":-56.413464,"median":-3.369868,"eighty":13.934648,"marketCap":8141409573},{"date":"2025-05-30","current":-37.924397,"twenty":-56.413464,"median":-3.387485,"eighty":13.934648,"marketCap":8964698181},{"date":"2025-06-06","current":-39.757882,"twenty":-56.413464,"median":-3.411914,"eighty":13.934648,"marketCap":9422080742},{"date":"2025-06-13","current":-44.75817,"twenty":-56.413464,"median":-3.415949,"eighty":13.934648,"marketCap":10611275398},{"date":"2025-06-20","current":-41.276192,"twenty":-56.413464,"median":-3.420731,"eighty":13.934648,"marketCap":9766586790},{"date":"2025-06-27","current":-42.699652,"twenty":-56.391895,"median":-3.438104,"eighty":13.922755,"marketCap":10131692838},{"date":"2025-07-04","current":-41.543655,"twenty":-56.391895,"median":-3.44468,"eighty":13.922755,"marketCap":9857863302},{"date":"2025-07-11","current":-46.206161,"twenty":-56.391895,"median":-3.469159,"eighty":13.922755,"marketCap":10953181447},{"date":"2025-07-18","current":-53.564112,"twenty":-56.391895,"median":-3.482303,"eighty":13.922755,"marketCap":12687435176},{"date":"2025-07-25","current":-51.066284,"twenty":-56.391895,"median":-3.514529,"eighty":13.922755,"marketCap":12139776103},{"date":"2025-08-01","current":-50.22475,"twenty":-56.391895,"median":-3.589151,"eighty":13.922755,"marketCap":11865946567},{"date":"2025-08-08","current":-53.18247,"twenty":-56.391895,"median":-7.200248,"eighty":13.922755,"marketCap":12596158664},{"date":"2025-08-15","current":-55.192072,"twenty":-56.391895,"median":-11.122318,"eighty":13.922755,"marketCap":13052541224},{"date":"2025-08-22","current":-55.752863,"twenty":-57.774713,"median":-11.335383,"eighty":13.922755,"marketCap":13143817736},{"date":"2025-08-29","current":-56.258629,"twenty":-57.774713,"median":-11.34716,"eighty":13.922755,"marketCap":13326370760},{"date":"2025-09-05","current":-171.005462,"twenty":-80.999729,"median":-11.34716,"eighty":13.922755,"marketCap":15060624489},{"date":"2025-09-12","current":-173.767346,"twenty":-82.276481,"median":-11.34716,"eighty":13.922755,"marketCap":15331415304},{"date":"2025-09-19","current":-169.725699,"twenty":-82.58333,"median":-11.34716,"eighty":13.922755,"marketCap":14964195775},{"date":"2025-09-26","current":-153.463683,"twenty":-82.851859,"median":-11.34716,"eighty":13.922755,"marketCap":13495317662},{"date":"2025-10-03","current":-185.056471,"twenty":-83.064154,"median":-11.352265,"eighty":13.910863,"marketCap":16312368818},{"date":"2025-10-10","current":-169.796368,"twenty":-83.220688,"median":-11.348775,"eighty":13.922755,"marketCap":14945410537},{"date":"2025-10-17","current":-151.277947,"twenty":-83.756141,"median":-11.37254,"eighty":13.922755,"marketCap":13305060600},{"date":"2025-10-24","current":-146.676373,"twenty":-84.447774,"median":-11.37254,"eighty":13.922755,"marketCap":12905038392},{"date":"2025-10-31","current":-152.64629,"twenty":-84.624193,"median":-11.37254,"eighty":13.922755,"marketCap":13450321704},{"date":"2025-11-07","current":-144.485392,"twenty":-85.250381,"median":-11.37254,"eighty":13.922755,"marketCap":12723277288},{"date":"2025-11-14","current":-147.164496,"twenty":-85.777895,"median":-11.37254,"eighty":13.922755,"marketCap":12995918944},{"date":"2025-11-21","current":-133.84826,"twenty":-86.066041,"median":-11.37254,"eighty":13.922755,"marketCap":11814471767},{"date":"2025-11-28","current":-138.493216,"twenty":-86.277112,"median":-11.37254,"eighty":13.922755,"marketCap":12268874528},{"date":"2025-12-05","current":-136.207289,"twenty":-87.682255,"median":-11.37254,"eighty":13.922755,"marketCap":12087113423},{"date":"2025-12-12","current":-133.911368,"twenty":-87.902749,"median":-11.37254,"eighty":13.922755,"marketCap":11905352319},{"date":"2025-12-19","current":-128.497409,"twenty":-89.023351,"median":-11.37254,"eighty":13.922755,"marketCap":11450949559},{"date":"2025-12-24","current":-129.115057,"twenty":-89.343343,"median":-11.58276,"eighty":13.922755,"marketCap":11541830111},{"date":"2026-01-02","current":-129.621563,"twenty":-89.385148,"median":-11.776052,"eighty":13.934648,"marketCap":11632710663},{"date":"2026-01-09","current":-133.340226,"twenty":-90.855167,"median":-22.789601,"eighty":13.934648,"marketCap":11996232871},{"date":"2026-01-16","current":-135.809309,"twenty":-96.214774,"median":-24.4212,"eighty":13.934648,"marketCap":12258074528},{"date":"2026-01-23","current":-134.932765,"twenty":-97.941067,"median":-25.252446,"eighty":13.934648,"marketCap":12167273976},{"date":"2026-01-30","current":-158.375813,"twenty":-100.15633,"median":-25.653279,"eighty":13.934648,"marketCap":14346487225},{"date":"2026-02-06","current":-163.974176,"twenty":-116.245243,"median":-25.653279,"eighty":13.934648,"marketCap":14891290537},{"date":"2026-02-13","current":-162.043578,"twenty":-120.222251,"median":-25.684915,"eighty":13.922755,"marketCap":14800489985},{"date":"2026-02-20","current":-168.250715,"twenty":-121.922853,"median":-25.570127,"eighty":13.94654,"marketCap":15345293298},{"date":"2026-02-27","current":-152.638791,"twenty":-123.147379,"median":-25.570127,"eighty":13.94654,"marketCap":14074085569},{"date":"2026-03-06","current":-145.937152,"twenty":-125.836872,"median":-25.570127,"eighty":13.94654,"marketCap":13347681152},{"date":"2026-03-13","current":-141.315211,"twenty":-128.463999,"median":-25.570127,"eighty":13.94654,"marketCap":12984478944},{"date":"2026-03-20","current":-136.89247,"twenty":-128.88509,"median":-25.570127,"eighty":13.94654,"marketCap":12530476184},{"date":"2026-03-27","current":-135.252627,"twenty":-129.286477,"median":-26.222352,"eighty":13.872469,"marketCap":12348875080},{"date":"2026-04-02","current":62.622294,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":12802877840},{"date":"2026-04-10","current":62.758937,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":12929774294},{"date":"2026-04-17","current":58.345701,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":12025594273},{"date":"2026-04-24","current":57.903729,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":11935176271},{"date":"2026-04-30","current":55.696119,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":11483086261},{"date":"2026-05-08","current":53.318298,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":11030996251},{"date":"2026-05-15","current":47.947764,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":9945980226},{"date":"2026-05-22","current":45.436272,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":9403472214},{"date":"2026-05-29","current":41.795837,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":8680128197},{"date":"2026-06-05","current":40.865781,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":8499292193},{"date":"2026-06-12","current":40.893441,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":8499292193},{"date":"2026-06-18","current":37.757596,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":7866366179},{"date":"2026-06-26","current":36.11832,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":7488094170},{"date":"2026-07-03","current":38.700332,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":8029402183},{"date":"2026-07-10","current":37.006407,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":7668530175},{"date":"2026-07-17","current":37.309002,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":7758748177},{"date":"2026-07-24","current":38.168077,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":7939184181},{"date":"2026-07-31","current":38.961518,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"marketCap":8119620185},{"date":"2026-08-07","current":39.102047,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"marketCap":8164729186},{"date":"2026-08-14","current":37.110765,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"marketCap":7758748177},{"date":"2026-08-21","current":37.674785,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"marketCap":7894075180}],"updateTime":1787511207161},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"00460\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2624525984","title":"Asian Penny Stocks Under US$10B Market Cap: 3 Picks To Consider","url":"https://stock-news.laohu8.com/highlight/detail?id=2624525984","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624525984?lang=en_us&edition=fundamental","pubTime":"2026-04-02 06:02","pubTimestamp":1775080964,"startTime":"0","endTime":"0","summary":"Amidst global market volatility driven by geopolitical tensions and fluctuating energy prices, Asian markets have been navigating a complex landscape. This environment has prompted investors to look beyond traditional large-cap stocks, turning their attention to opportunities in smaller or newer companies often categorized as penny stocks. Though the term 'penny stock' may seem outdated, it remains relevant for those seeking potential growth in companies with solid financial foundations...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/3071000-choice2-main-header/1585186751359","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3071000-choice2-main-header/1585186751359"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/sg/capital-goods/sgx-bs6/yangzijiang-shipbuilding-holdings-shares/news/asian-penny-stocks-under-us10b-market-cap-3-picks-to-conside","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/sg/capital-goods/sgx-bs6/yangzijiang-shipbuilding-holdings-shares/news/asian-penny-stocks-under-us10b-market-cap-3-picks-to-conside","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999013486.USD","BK1615","SGXZ43160589.SGD","SG9999013460.SGD","SGXZ24219693.SGD","BK6515","LU0620787316.HKD","SGXZ27511609.SGD","SG9999013478.USD","LU0516423174.USD","BK1613","80020","BK8040","LU1242518931.SGD","SG9999014484.SGD","LU0516422440.USD","BK6057","SG9999014492.USD","LU0516422366.SGD","LU0164939612.USD","SG9999004360.SGD","SG9999000475.SGD","BS6.SI","LU0082770016.USD","BK1109","00460","LU0082770016.SGD","LU0979878070.USD","SG9999003826.SGD","SGXZ58947870.SGD","BK6504","BK6081","LU0516423091.SGD","SG9999002679.SGD","SG9999016042.SGD","SG9999000343.SGD","LU0516422952.EUR","00020","LU1242518857.USD","BK6065"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624519568","title":"Assessing Sihuan Pharmaceutical Holdings Group’s Valuation After Earnings Turnaround And Positive Bireociclib Phase 3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2624519568","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624519568?lang=en_us&edition=fundamental","pubTime":"2026-04-01 20:30","pubTimestamp":1775046635,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group (SEHK:460) has drawn investor attention after reporting full year 2025 earnings, showing CNY 2,618.01 million in sales and CNY 179.7 million in net income, alongside positive final Phase 3 data for Bireociclib.\nSee our latest analysis for Sihuan Pharmaceutical Holdings Group.\nThe earnings turnaround and Bireociclib news sit alongside a 17.9% 90 day share price return and a 121.2% 1 year total shareholder return. However, the 5 year total shareholder return...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/assessing-sihuan-pharmaceutical-holdings-groups-valuation-af-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/assessing-sihuan-pharmaceutical-holdings-groups-valuation-af-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["00460","BK1515","BK1191","BK1593","DCF","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624597384","title":"BRIEF-Sihuan Pharma Signs Strategic Collaboration With Biocytogen For AI-Driven Drug R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2624597384","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624597384?lang=en_us&edition=fundamental","pubTime":"2026-04-01 18:53","pubTimestamp":1775040780,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Signs Strategic Collaboration With Biocytogen For AI-Driven Drug R&DApril 1  - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:SIGNS STRATEGIC COLLABORATION WITH BIOCYTOGEN FOR AI-DRIVEN DRUG R&DFIRST PROJECT FOCUSES ON NEXT-GENERATION WEIGHT LOSS DRUGFurther company coverage: 0460.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nFWN40K0HF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK0216","688796","BK1515","BK1191","BK1600","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143375483","title":"SIHUAN PHARM and BIOCYTOGEN-B Forge Strategic Alliance to Accelerate Innovative Drug Development in Weight Loss and Other Areas Using AI-Powered Human Antibody Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1143375483","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143375483?lang=en_us&edition=fundamental","pubTime":"2026-04-01 17:12","pubTimestamp":1775034756,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) has announced that the Group has officially entered into a strategic collaboration agreement with Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Stock Code: 688796.SH;...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","BK1600","CHAT","BK1574","AIPO","688796","BK1515","BK1191","BK1593","06978","00460","159992","02315","BK1161","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146966129","title":"Sihuan Pharm partners with Biocytogen to accelerate AI-driven fully human antibody R&D for next-gen weight-loss therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1146966129","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146966129?lang=en_us&edition=fundamental","pubTime":"2026-04-01 17:07","pubTimestamp":1775034439,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharm) has signed a strategic collaboration agreement with Biocytogen Pharmaceuticals (Beijing) Co., Ltd. The partnership combines Sihuan Pharm’s...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624961275","title":"Sihuan Pharma signs strategic R&D collaboration with Biocytogen on AI antibody platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2624961275","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624961275?lang=en_us&edition=fundamental","pubTime":"2026-04-01 17:02","pubTimestamp":1775034170,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical signed a strategic collaboration agreement with Biocytogen to jointly develop innovative drugs, including a weight-loss program, using an AI-driven fully human antibody discovery platform.First project targets a next-generation obesity candidate aimed at boosting energy expenditure while preserving or increasing muscle mass.Biocytogen will provide technical support through its target-humanized mouse models, in vivo efficacy platforms, fully human antibody discovery tools, and AI-enabled R&D systems.Sihuan will contribute drug development, large-scale manufacturing, and global commercialization capabilities to advance R&D and rollout of resulting products.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sihuan Pharm","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL60qPT6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","00460","BK1593","BK1191","BK4121","LU2237957811.SGD","BK1515","IE00B64QTZ34.USD","LU2237957902.USD","IE00B19Z6F94.USD","BK4585","TECH","IE0034390439.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624961915","title":"Sihuan Pharma - First Project Focuses on Next-Generation Weight Loss Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2624961915","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624961915?lang=en_us&edition=fundamental","pubTime":"2026-04-01 17:01","pubTimestamp":1775034085,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nFWN40K0HF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1191","BK1593","BK1600","00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166458779","title":"Sihuan Pharma: March 2026 Share Capital Stable, No New Issuances or Treasury Movements","url":"https://stock-news.laohu8.com/highlight/detail?id=1166458779","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166458779?lang=en_us&edition=fundamental","pubTime":"2026-04-01 16:25","pubTimestamp":1775031904,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharma) reported that its share capital structure remained unchanged in March 2026. The company’s authorised share capital stood at HKD 1.00 billion,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175835368","title":"Sihuan Pharmaceutical Declares RMB 0.0096 Final Dividend for FY 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1175835368","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175835368?lang=en_us&edition=fundamental","pubTime":"2026-03-31 12:24","pubTimestamp":1774931057,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. announced a final ordinary cash dividend of RMB 0.0096 per share for the financial year ended 31 December 2025. Using the declared exchange rate of RMB 1 :...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129525813","title":"Sihuan Pharmaceutical Returns to Profitability with FY Net Income of 180 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1129525813","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129525813?lang=en_us&edition=fundamental","pubTime":"2026-03-31 12:18","pubTimestamp":1774930711,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical (00460) announced its annual results for the period ended December 31, 2025. Total revenue reached approximately RMB 2.618 billion, representing an increase of about 37.7%...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","00460","BK1600","BK1191","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188285155","title":"Sihuan Pharmaceutical 2025 Results: Revenue Climbs 37.7%, Turns Profitable on Medical Aesthetics Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1188285155","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188285155?lang=en_us&edition=fundamental","pubTime":"2026-03-31 12:04","pubTimestamp":1774929877,"startTime":"0","endTime":"0","summary":"Hong Kong-listed Sihuan Pharmaceutical reported FY2025 revenue of RMB2.62 billion, up 37.7% year-on-year, driven mainly by a near-doubling of medical aesthetics sales to RMB1.49 billion. Gross profit...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623437405","title":"Sihuan Pharma FY25 revenue climbs 37.7% to RMB 2.6 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2623437405","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623437405?lang=en_us&edition=fundamental","pubTime":"2026-03-31 12:01","pubTimestamp":1774929698,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical swung to profit of RMB 185 million for 2025, reversing a loss a year earlier.Revenue climbed 37.7% to RMB 2.6 billion, driven primarily by medical aesthetics.Operating profit rose to RMB 607 million, helped by higher medical aesthetics sales, tighter cost control, and improved innovative drug revenue.Board proposed a final cash dividend of RMB 0.96 cents per share; cash and equivalents, wealth management products, pledged deposits, and time deposits totaled RMB 4.4 billion at year-end.Group guided 2026 as the first year of a new three-year plan, targeting deeper domestic penetration and faster overseas expansion in medical aesthetics while accelerating innovative drug commercialization.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investmen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL6CDSrG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1515","BK1593","00460","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623051374","title":"Sihuan Pharma -  FY Profit Attributable RMB179.7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2623051374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623051374?lang=en_us&edition=fundamental","pubTime":"2026-03-31 12:01","pubTimestamp":1774929694,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40I1AP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00460","BK1515","BK1191","BK1593","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623034374","title":"Sihuan Pharma -  Final Cash Dividend of RMB0.96 Cents per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2623034374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623034374?lang=en_us&edition=fundamental","pubTime":"2026-03-31 12:01","pubTimestamp":1774929662,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nPLXC00322:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1593","BK1191","00460","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623315221","title":"Xuanzhu Biopharma FY25 loss narrows 55.9% to RMB 250 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623315221","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623315221?lang=en_us&edition=fundamental","pubTime":"2026-03-30 17:58","pubTimestamp":1774864687,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical posted a net loss of RMB 250 million, narrowing 55.9%.Operating expenses fell 56.6% to RMB 250 million.Commercial rollout accelerated with two oncology launches in 2025, while cash and cash equivalents climbed to RMB 650 million following the October IPO.For 2026, focus remains on expanding NRDL access, advancing indication expansions and pipeline development, while tightening cost management.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xuanzhu Biopharmaceutical Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL414TVf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00460","BK1600","BK1593","BK1515","02575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621306116","title":"Sihuan Pharmaceutical unit publishes BRIGHT-2 Phase 3 results for biloxcilib plus fulvestrant in JAMA Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2621306116","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621306116?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:48","pubTimestamp":1774352903,"startTime":"0","endTime":"0","summary":"Sihuan said its majority-owned unit Xuanzhu Biopharma published final Phase 3 BRIGHT-2 results for CDK2/4/6 inhibitor piruoxib in combination with fulvestrant in JAMA Oncology.The company stated the study reported a median progression-free survival of 14.7 months versus 7.3 months, with a 46% reduction in risk of disease progression or death.Sihuan said the treatment achieved an objective response rate of 50.3% versus 16.7% in patients with measurable disease.The company said the drug has received China approvals for use in HR+/HER2- advanced or metastatic breast cancer in combination with fulvestrant, as monotherapy, and in combination with an aromatase inhibitor.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sihuan Pharmaceutical Ho","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL3kmNYg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1600","BK1515","BK1593","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621069888","title":"Xuanzhu Biopharmaceutical reports BRIGHT-2 Phase 3 results for Bireociclib plus fulvestrant in HR+/HER2- breast cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2621069888","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621069888?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:06","pubTimestamp":1774350387,"startTime":"0","endTime":"0","summary":"Xuanzhu reported final Phase 3 BRIGHT-2 results for its breast cancer product bireociclib in combination with fulvestrant, with the analysis published in JAMA Oncology.The company said median progression-free survival was 14.7 months versus 7.3 months for placebo plus fulvestrant, with a 46% reduction in risk of progression or death .In patients with measurable disease, the objective response rate was 50.3% versus 16.7% for the control group.Xuanzhu said bireociclib has been approved in China for use with fulvestrant in HR+/HER2- advanced or metastatic breast cancer after progression on prior endocrine therapy, positioning it for broader clinical adoption.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xuanzhu Biopharmaceutical Co. Ltd","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL20tgp6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1600","02575","BK1593","BK1191","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621714840","title":"Xuanzhu Biopharmaceutical completes enrollment of 500 patients in China Phase 3 trial of anaprazole sodium enteric-coated tablets for reflux esophagitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2621714840","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621714840?lang=en_us&edition=fundamental","pubTime":"2026-03-22 18:08","pubTimestamp":1774174088,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical completes enrollment of 500 patients in China Phase 3 trial of anaprazole sodium enteric-coated tablets for reflux esophagitis. Xuanzhu reported full enrollment of 500 adults in a China Phase 3 trial of its product Anaprazole Sodium enteric-coated tablets  for reflux esophagitis.The trial milestone positions the program for potential expansion beyond Anaprazole’s existing China approval for duodenal ulcer treatment.Completion of enrollment may support near-term differentiation in the domestic reflux esophagitis market by advancing a locally developed therapy through late-stage development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xuanzhu Biopharmaceutical Co. Ltd. published the original content used to g","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260322:nNDL6JMbm8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1593","02575","BK1600","BK1191","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621714823","title":"Xuanzhu Biopharmaceutical completes enrollment of 500 subjects in China Phase III reflux esophagitis trial of anaprazole sodium tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2621714823","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621714823?lang=en_us&edition=fundamental","pubTime":"2026-03-22 18:08","pubTimestamp":1774174083,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical completes enrollment of 500 subjects in China Phase III reflux esophagitis trial of anaprazole sodium tablets. Xuanzhu Biopharma reported completion of enrollment of 500 subjects in a China Phase III trial of anaprazole sodium enteric-coated tablets  for adult reflux esophagitis.The pivotal study is multi-center, randomized, double-blind, double-dummy, and active-controlled.The primary endpoint is endoscopic healing rate within 8 weeks of treatment.Secondary endpoints include endoscopic healing rate at week 4 and symptom changes at week 4 and week 8.No trial results were reported in the announcement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xuanzhu Biopharmaceutical Co. Ltd. published the original conten","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260322:nNDL8162Qw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1600","BK1191","00460","02575","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161078965","title":"Sihuan Pharma (00460) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1161078965","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161078965?lang=en_us&edition=fundamental","pubTime":"2026-03-19 16:43","pubTimestamp":1773909795,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (stock code: 00460) has announced that its board of directors will convene on 31 March 2026. Key agenda items include: • Approval and publication of the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":111,"code":"91000000","status":"200"}]}}